SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (3623)12/13/1997 9:20:00 PM
From: LoLoLoLita  Read Replies (1) of 23519
 
Well Said Zebra,

I'm amazed at all the nit-picking (both here and from Paine-Webber
in the CC) at trying to second-guess the company's production
figures like this is another BRE-X. What do you guys want,
some kind of real-time production counter on the Vivus web-site? And full-time audit teams from KPMG and Price-Waterhouse on the
production floors? Gimme a Break!

As far as Michael I. Levitt goes, I for one am glad to see that
they hired someone who achieved a heck of a lot with *just*
a B.S. in Pharmacy. To me (someone who gets a lot of mail
addressed to me as "Dr." for no reason), that means he gets
things done.

Just a reminder. If they make 20 cents this Q4 (down from 56 cents
in Q3), they'll make $1.05/share for the year. If share price stays flat, the TTM PE will be 11.5--pretty darn cheap considering the I/B/E/S forecast of 75% year-to-year growth for FY 98.

My hat goes off to Leland for keeping his temper in the CC and not snapping at the idiots from The Street who kept trying to show him a liar.

Cheers, David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext